Back to search

Article

The contribution of multiplexing single cell RNA sequencing in acute myeloid leukemia

2023-02-22

Abstract excerpt

After decades during which the treatment of acute myeloid leukemia consisted in cytarabine + anthracycline, targeted therapies have appeared, first based on monoclonal antibodies (anti-CD52, anti-CD123) and then on specific inhibitors of molecular mutations (anti-IDH, IDH2 or FLT3). What should be the place of these therapeutic options considering the tumor heterogeneity inherent to leukemia diagnosis and the clon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7eb5360-7732-586a-a8aa-3fea730b1eea
DOI
10.21203/rs.3.rs-2565353/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The contribution of multiplexing single cell RNA sequencing in acute myeloid leukemiaDOI 10.21203/rs.3.rs-2565353/v1
Select a neighboring publication to make it the new centre.